Serum Uric Acid Level as a Prognostic Marker in Patients With Acute Respiratory Distress Syndrome

Abstract

Purpose:

Uric acid acts as both a pathogenic inflammatory mediator and an antioxidative agent. Several studies have shown that uric acid level correlates with the incidence, severity, and prognosis of pulmonary diseases. However, the association between uric acid level and acute respiratory distress syndrome (ARDS) has not been studied. This study was conducted to elucidate how serum uric acid level is related with clinical prognosis of ARDS.

Methods:

A retrospective cohort study with propensity score matching was conducted at a medical intensive care unit of a tertiary teaching hospital. The medical records of patients diagnosed with ARDS admitted from 2005 through 2011 were reviewed.

Results:

Two hundred thirty-seven patients with ARDS met the inclusion criteria. Patients with a serum uric acid level <3.0 mg/dL were classified into the low uric acid group, and those with a level ≥3 mg/dL were classified into the normal to high uric acid group. We selected 40 patients in each group using propensity score matching. A higher percentage of patients in the low uric acid group experienced clinical improvement in ARDS. More patients died from sepsis in the normal to high uric acid group. Kaplan-Meier analysis showed that a low serum uric acid level was significantly associated with better survival rate.

Conclusion:

In patients with ARDS, a low serum uric acid level may be a prognostic marker of a low risk of in-hospital mortality.

Keywords

uric acid respiratory distress syndrome adult treatment outcome prognosis survival analysis mortality

Get full access to this article

View all access options for this article.

References

Fox

. Metabolic basis for disorders of purine nucleotide degradation. Metabolism. 1981;30(6):616–634.

Maxwell

Thomason

Sandler

. Antioxidant status in patients with uncomplicated insulin-dependent and non-insulin-dependent diabetes mellitus. Eur J Clin Invest. 1997;27(6):484–490.

Ames

Cathcart

Schwiers

Hochstein

. Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis. Proc Natl Acad Sci U S A. 1981;78(11):6858–6862.

Church

Ward

. Uric acid is reduced in the substantia nigra in Parkinson’s disease: effect on dopamine oxidation. Brain Res Bull. 1994;33(4):419–425.

Hooper

Scott

Zborek

. Uric acid, a peroxynitrite scavenger, inhibits CNS inflammation, blood–CNS barrier permeability changes, and tissue damage in a mouse model of multiple sclerosis. FASEB J. 2000;14(5):691–698.

Sanders

Huecksteadt

Sturrock

Hoidal

. Regulation of oxidant production in acute lung injury. Chest. 1999;116(suppl 1):56S–61S.

Schmidt

Luboeinski

Markart

. Alveolar antioxidant status in patients with acute respiratory distress syndrome. Eur Respir J. 2004;24(6):994–999.

Horsfall

Nazareth

Petersen

. Serum uric acid and the risk of respiratory disease: a population-based cohort study. Thorax. 2014;69(11):1021–1026.

Perlstein

Gumieniak

Hopkins

. Uric acid and the state of the intrarenal renin-angiotensin system in humans. Kidney Int. 2004;66(4):1465–1470.

10.

Lewis

Maxwell

. Risk factor control is key in diabetic nephropathy. Practitioner. 2014;258(1768):13–17, 2.

11.

Johnson

Nakagawa

Sanchez-Lozada

. Sugar, uric acid, and the etiology of diabetes and obesity. Diabetes. 2013;62(10):3307–3315.

12.

Bartziokas

Papaioannou

Loukides

. Serum uric acid as a predictor of mortality and future exacerbations of COPD. Eur Respir J. 2014;43(1):43–53.

13.

Embarak

Sileem

Abdrabboh

Mokhtar

. Serum uric acid as a biomarker for prediction of outcomes of patients hospitalized for acute exacerbation of chronic obstructive pulmonary disease. Egypt J Bronchol. 2014;8(2):115–120.

14.

Aida

Shibata

Osaka

. The relationship between serum uric acid and spirometric values in participants in a health check: the Takahata study. Int J Med Sci. 2011;8(6):470–478.

15.

Fabbri

Rabe

. From COPD to chronic systemic inflammatory syndrome? Lancet. 2007;370(9589):797–799.

16.

Newman

Loyd

English

. Effects of 100% oxygen on lung vascular function in awake sheep. J Appl Physiol Respir Environ Exerc Physiol. 1983;54(5):1379–1386.

17.

Freeman

Crapo

. Biology of disease: free radicals and tissue injury. Lab Invest. 1982;47(5):412–426.

18.

Leff

Parsons

Day

. Serum antioxidants as predictors of adult respiratory distress syndrome in patients with sepsis. Lancet. 1993;341(8848):777–780.

19.

Igic

Behnia

. Properties and distribution of angiotensin I converting enzyme. Curr Pharm Des. 2003;9(9):697–706.

20.

Wang

Alam

Zagariya

. Apoptosis of lung epithelial cells in response to TNF-alpha requires angiotensin II generation de novo. J Cell Physiol. 2000;185(2):253–259.

21.

The ADTF. Acute respiratory distress syndrome: the Berlin definition. JAMA. 2012;307(23):2526–2533.

22.

Geren

Bendich

Bodansky

Brown

. The fate of uric acid in man. J Biol Chem. 1950;183(1):21–31.

23.

Wang

Chen

Wang

. Outcome and prognostic factors for patients with non-small-cell lung cancer and severe radiation pneumonitis. Int J Radiat Oncol Biol Phys. 2002;54(3):735–741.

24.

Huang

Hsueh

. Renal hypouricemia is an ominous sign in patients with severe acute respiratory syndrome. Am J Kidney Dis. 2005;45(1):88–95.

25.

Elshafey

Mossalam

AMA

Makharita

Elewa

. Prognostic role of serum uric acid in acute respiratory distress syndrome patients: a preliminary study. Egypt J Chest Dis Tuberc. 2015;64(1):197–202.

26.

Lopez

. Serum uric acid levels among patients with chronic obstructive pulmonary disease. Chest. 2003;124(4):168S–a-S.

27.

Shimizu

Nagaya

Satoh

. Serum uric acid level increases in proportion to the severity of pulmonary thromboembolism. Circ J. 2002;66(6):571–575.

28.

Nagaya

Uematsu

Satoh

. Serum uric acid levels correlate with the severity and the mortality of primary pulmonary hypertension. Am J Respir Crit Care Med. 1999;160(2):487–492.

29.

Elsayed

Nakashima

Postlethwait

. Measurement of uric acid as a marker of oxygen tension in the lung. Arch Biochem Biophys. 1993;302(1):228–232.

30.

Mateos Anton

Garcia Puig

Gomez Fernandez

. Degradation of purine nucleotides in patients with chronic obstruction to airflow [in Spanish]. Med Clin (Barc). 1989;92(9):328–330.

31.

Lou

Liu

Wang

. Effects of acute systematic hypoxia on human urinary metabolites using LC–MS-based metabolomics. High Alt Med Biol. 2014;15(2):192–202.

32.

Pascual-Figal

Hurtado-Martinez

Redondo

. Hyperuricaemia and long-term outcome after hospital discharge in acute heart failure patients. Eur J Heart Fail. 2007;9(5):518–524.

33.

Hwang

Lee

. Relationship between serum uric acid level and hypertension: a retrospective cohort study. Korean J Fam Med. 2010;31(9):672–678.

34.

Sahebjani

. Changes in urinary uric acid excretion in obstructive sleep apnea before and after therapy with nasal continuous positive airway pressure. Chest. 1998;113(6):1604–1608.

35.

Beck

. Hypouricemia in the syndrome of inappropriate secretion of antidiuretic hormone. N Engl J Med. 1979;301(10):528–530.

36.

Giovannini

Chiarla

Giuliante

. Biochemical and clinical correlates of hypouricemia in surgical and critically ill patients. Clin Chem Lab Med. 2007;45(9):1207–1210.

37.

Bouadma

Sonneville

Garrouste-Orgeas

. Ventilator-associated events: prevalence, outcome, and relationship with ventilator-associated pneumonia. Crit Care Med. 2015;43(9):1798–1806.

38.

Zhu

Cao

. The relationship between serum levels of uric acid and prognosis of infection in critically ill patients. World J Emerg Med. 2012;3(3):186–190.

39.

Galley

Davies

Webster

. Xanthine oxidase activity and free radical generation in patients with sepsis syndrome. Crit Care Med. 1996;24(10):1649–1653.

40.

Chuang

Shiesh

Chi

. Serum total antioxidant capacity reflects severity of illness in patients with severe sepsis. Crit Care. 2006;10(1):R36.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

3.17 MB

0.00 MB